Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood–Brain Barrier of Human Brain and Glioblastoma
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The knowledge of transporter protein expression and function at the human blood–brain barrier (BBB) is critical to prediction of drug BBB penetration and design of strategies for improving drug delivery to the brain or brain tumor. This study determined absolute transporter protein abundances in isolated microvessels of human normal brain (N = 30), glioblastoma (N = 47), rat (N = 10) and mouse brain (N = 10), and cell membranes of MDCKII cell lines, using targeted proteomics. In glioblastoma microvessels, efflux transporters (ABCB1 and ABCG2), monocarboxylate transporter 1 (MCT1), glucose transporter 1 (GLUT1), sodium–potassium pump (Na/K ATPase), and Claudin‐5 protein levels were significantly reduced, while large neutral amino acid transporter 1 (LAT1) was increased and GLU3 remained the same, as compared with human normal brain microvessels. ABCC4, OATP1A2, OATP2B1, and OAT3 were undetectable in microvessels of both human brain and glioblastoma. Species difference in BBB transporter abundances was noted. Cellular permeability experiments and modeling simulations suggested that not a single apical uptake transporter but a vectorial transport system consisting of an apical uptake transporter and basolateral efflux mechanism was required for efficient delivery of poor transmembrane permeability drugs from the blood to brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Sarkaria, J. N., Hu, L. S., Parney, I. F., Pafundi, D. H., Brinkmann, D. H., Laack, N. N., Giannini, C., Burns, T. C., Kizilbash, S. H., Laramy, J. K., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox175 · Cited by 746 · cited 1×
“In spite of enhanced drug penetration into bulky tumor areas, insufficient penetration of potentially effective therapeutic agents into invasive, infiltrative tumor regions with an intact BBB represents a significant barrier to long-term, efficacious treatments.(3) The BBB consists of both physical and biochemical bar…”
BackgroundShawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., Jacob, A., Chassoux, F., Daumas-Duport, C., Couraud, P.-O., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200129p · Cited by 372 · cited 2×
“Quantitative targeted proteomics indicated that only ABCC4 was expressed at quantifiable but low levels (< 5% of ABCG2 level) in isolated microvessels of human or rodent brain, while ABCC1, 2, 3, 5, and 6 were undetectable.(12,26,34) Immunofluorescence microscopy analysis of protein expression of ABCC1–ABCC6 in human…”
BackgroundResultOse, A., Kusuhara, H., Endo, C., Tohyama, K., Miyajima, M., Kitamura, S., & Sugiyama, Y. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029454 · Cited by 148 · cited 1×
“However, the ability of human OATP1A2 (or rodent Oatp1a4) to act as a facilitator for drug delivery from the blood to brain remains controversial.(13,14) The common hypothesis that OATP1A2 can mediate transport of substrate drugs across the BBB is largely generated from in vitro drug uptake experiments using oocytes,…”
BackgroundLi, J., Wu, J., Bao, X., Honea, N., Xie, Y., Kim, S., Sparreboom, A., & Sanai, N. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0983 · Cited by 68 · cited 10×
“AZD1775, a good ABCB1 substrate, exhibited good brain and tumor penetration in glioblastoma patients, while it poorly penetrated into mouse brain.(15,29) Given the less functional importance of ABCB1 at human BBB, it is plausible that some ABCB1 substrates may retain sufficient BBB permeability in humans though they s…”
BackgroundMethodSelf-citation
Cited by
Factors influencing the blood-brain barrier permeability
Zhao, Y., Gan, L., Ren, L., Lin, Y., Ma, C., & Lin, X. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147937 · Cited by 291
The blood–tumour barrier in cancer biology and therapy
Steeg, P. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00529-6 · Cited by 287
Zhang, W., Oh, J.-H., Zhang, W., Rathi, S., Le, J., Talele, S., Sarkaria, J. N., & Elmquist, W. F. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03574-1 · Cited by 19
“Bao et al. reported a 6.5-fold higher P-gp expression in rats (22.09 vs. 3.38, fmol/µg protein) and a 2.5-fold higher in mice (8.57 vs. 3.38) than that in humans [87].”
InfluentialTanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Metadata
- Authors
- Bao, X., Wu, J., Xie, Y., Kim, S., Michelhaugh, S., Jiang, J., Mittal, S., Sanai, N., & Li, J.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2019-12-10
- Volume
- 107
- Issue
- 5
- Pages
- 1116-1127
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2982466751
- Cited by
- 92
- References
- 5
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood–Brain Barrier of Human Brain and Glioblastoma. https://app.cochat.ai/papers/10.1002/cpt.1710
- The paper
- Bao, X., Wu, J., Xie, Y., Kim, S., Michelhaugh, S., Jiang, J., Mittal, S., Sanai, N., & Li, J. (2020). Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood–Brain Barrier of Human Brain and Glioblastoma. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.1710
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.